Substituted 2,3-dihydro-1H-benzo[a]pyrano[2,3-c]phenazines as anti-angiogenic and anti-cancer agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9181265
APP PUB NO 20130289030A1
SERIAL NO

13997576

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel phenazine derivatives of formula (I)

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE CATHOLIQUE DE LOUVAINPLACE DE L'UNIVERSITÉ 1 LOUVAIN-LA-NEUVE B-1348
UNIVERSITE LIBRE DE BRUXELLESBRUXELLES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chataigne, Gabrielle Lille, FR 1 8
Feron, Olivier Wezembeek-Oppem, BE 10 52
Kiss, Robert Sint Pieters-Leeuw, BE 27 93
Lamy, Carole Montigny le Bretonneux, FR 1 8
Leclercq, Joelle Beaufays, BE 2 8
Riant, Olivier Brussels, BE 3 10
Vandelaer, Nicolas Bossut-Gottechain, BE 1 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 10, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00